Hattori Etsuko Yamamoto, Terada Yukinori, Takeuchi Yasuhide, Makino Yasuhide, Takada Shigeki, Sano Noritaka, Tanji Masahiro, Mineharu Yohei, Arakawa Yoshiki
Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
J Neurosurg Case Lessons. 2025 Apr 21;9(16). doi: 10.3171/CASE258.
Chronic expanding hematoma (CEH) is a rare disease characterized by slow expansion, especially reported after Gamma Knife radiosurgery (GKRS) for cerebral arteriovenous malformations. No cases have been reported following treatment for primary central nervous system lymphoma (PCNSL). Vascular endothelial growth factor and vascular endothelial growth factor receptor-1 (VEGFR-1) have been reported to be responsible for CEH induction.
A 56-year-old woman underwent partial tumor removal for PCNSL in the left temporo-occipital lobe at another hospital. One and a half months later, a new lesion was observed, and she underwent GKRS, including the residual lesion. She was treated with multiple chemotherapy regimens including R-MPV (rituximab, methotrexate, procarbazine, vincristine) but relapsed repeatedly and was administered tirabrutinib. Four years after GKRS, the gadolinium-enhanced lesion slowly grew. Tumor recurrence or radiation necrosis was suspected, and surgical removal was performed. The tissue was composed of nonmalignant brain tissue and fibrinized hematoma, which demonstrated strong expression of VEGFR-1 on immunostaining, and the pathological diagnosis was CEH.
In this patient, CEH could have resulted from VEGFR-1 expression due to GKRS. For a patient with slow lesion growth following GKRS for PCNSL, surgical removal should be considered, taking into account the possibility of CEH along with recurrence and radiation necrosis. https://thejns.org/doi/10.3171/CASE258.
慢性扩张性血肿(CEH)是一种罕见疾病,其特征为缓慢扩张,尤其在伽玛刀放射外科治疗(GKRS)脑动静脉畸形后有相关报道。原发性中枢神经系统淋巴瘤(PCNSL)治疗后尚无病例报告。血管内皮生长因子和血管内皮生长因子受体-1(VEGFR-1)据报道与CEH的诱发有关。
一名56岁女性在另一家医院接受了左颞枕叶PCNSL部分肿瘤切除术。一个半月后,发现一个新病灶,她接受了包括残留病灶在内的GKRS治疗。她接受了多种化疗方案,包括R-MPV(利妥昔单抗、甲氨蝶呤、丙卡巴肼、长春新碱),但多次复发,并接受了替拉鲁替尼治疗。GKRS治疗四年后,钆增强病灶缓慢增大。怀疑为肿瘤复发或放射性坏死,遂进行手术切除。组织由非恶性脑组织和纤维蛋白化血肿组成,免疫染色显示VEGFR-1表达强烈,病理诊断为CEH。
在该患者中,CEH可能是由于GKRS导致VEGFR-1表达所致。对于PCNSL患者在GKRS后病灶生长缓慢的情况,应考虑手术切除,同时考虑到CEH以及复发和放射性坏死的可能性。https://thejns.org/doi/10.3171/CASE258